APTX
$2.39
Aptinyx
($.02)
(.83%)
APTX
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  ($0.31)
Revenue:  $0.00 Mil
Tuesday
Nov 9
4:10 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when APTX reports earnings?
Beat
Meet
Miss

Where is APTX's stock price going from here?
Up
Flat
Down
Stock chart of APTX
Analysts
Summary of analysts' recommendations for APTX
Score
Grade
Pivots
Resistance
$2.52
$2.49
$2.44

$2.41

Support
$2.36
$2.33
$2.28
Tweet
Growth
Description
Aptinyx Inc. is a bio-pharmaceutical company. It focuses on discovery, development, and commercialization of novel, proprietary and synthetic small molecules for the treatment of brain and nervous system disorders. The company's product pipeline consists of NYX-2925, NYX-783 and NYX-458 which are in clinical stage. Aptinyx Inc. is based in IL, United States.